RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor.

ABSTRACT: INTRODUCTION: RhoB has been reported to exert positive and negative effects on cancer pathophysiology but an understanding of its role in breast cancer remains incomplete. Analysis of data from the Oncomine database showed a positive correlation between RhoB expression and positivity for both the Estrogen Receptor alpha (ERalpha) and the Progesterone Receptor (PR). METHODS: This finding was validated by our analysis of a tissue microarray constructed from a cohort of 113 patients and then investigated in human cell models. RESULTS: We found that RhoB expression in tissue was strongly correlated with ER and PR expression and inversely correlated with tumor grade, tumor size and count of mitosis. In human breast cancer cell lines, RhoB attenuation was associated with reduced expression of both ERalpha and PR, whereas elevation of RhoB was found to be associated with ERalpha overexpression. Mechanistic investigations suggested that RhoB modulates ERalpha expression controlling both its protein and mRNA levels, and that RhoB modulates PR expression by accentuating the recruitment of ERalpha and other major co-regulators to the promoter of PR gene. A major consequence of RhoB modulation was that RhoB differentially regulated the proliferation of breast cancer cell lines. Interestingly, we documented crosstalk between RhoB and ERalpha, with estrogen treatment leading to RhoB activation. CONCLUSIONS: Taken together, our findings offer evidence that in human breast cancer RhoB acts as a positive function to promote expression of ERalpha and PR in a manner correlated with cell proliferation.

Domaines

Cancer

Fichier principal

bcr3377.pdf (3.31 Mo)

BCR3377-S1.PDF (39.96 Ko)

BCR3377-S2.DOC (32 Ko)

BCR3377-S3.PDF (28.84 Ko)

BCR3377-S4.PDF (741.68 Ko)

BCR3377-S5.PDF (76.77 Ko)

bcr3377.xml (75.02 Ko)

Origine : Fichiers éditeurs autorisés sur une archive ouverte

Format : Autre

Ed. BMC : Connectez-vous pour contacter le contributeur

https://inserm.hal.science/inserm-00787288

Soumis le : lundi 11 février 2013-17:04:09

Dernière modification le : vendredi 22 décembre 2023-12:04:40

Archivage à long terme le : dimanche 12 mai 2013-03:58:12

Dates et versions

inserm-00787288 , version 1 (11-02-2013)

Identifiants

HAL Id : inserm-00787288 , version 1
DOI : 10.1186/bcr3377
PUBMED : 23339407

Citer

Claire Médale-Giamarchi, Isabelle Lajoie-Mazenc, Emilie Malissein, Elise Meunier, Bettina Couderc, et al.. RhoB modifies estrogen responses in breast cancer cells by influencing expression of the estrogen receptor.. Breast Cancer Research, 2013, 15 (1), pp.R6. ⟨10.1186/bcr3377⟩. ⟨inserm-00787288⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS UNIV-UT3 UT3-TOULOUSEINP

239 Consultations

509 Téléchargements